The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Characterization of glycopeptide-resistant enterococci from U.S. hospitals
Open accessAbstract
We examined 105 clinical isolates of glycopeptide-resistant enterococci collected from 31 U.S. hospitals in 14 states during May 1988 to July 1992. The isolates included 82 Enterococcus faecium, 8 E. faecalis, 6 Enterococcus spp., 5 E. gallinarum, 3 E. casseliflavus, and 1 E. raffinosus. The isolates were categorized into the following four phenotypes of glycopeptide resistance on the basis of their MIC patterns: (i) 70 VanA (vancomycin [Vm] MIC, > or = 64 micrograms/ml; teicoplanin [Tei] MIC, 16 to > or = 128 micrograms/ml), (ii) 26 VanB (Vm MIC, 16 to 1,024 micrograms/ml; Tei MIC, < or = 2 micrograms/ml), (iii) 5 VanC (Vm MIC, 4 to 16 micrograms/ml; Tei MIC, < or = 2 micrograms/ml) in E. gallinarum, and (iv) 3 E. casseliflavus and 1 E. raffinosus isolates for which Vm MICs were 4 to 16 micrograms/ml and Tei MICs were < or = 1 micrograms/ml were called unclassified. Of the 101 isolates with the VanA, VanB, and VanC phenotypes, 99 were confirmed by production of a specific 1,030-, 433-, or 796-bp polymerase chain reaction product, respectively, and hybridization with the respective gene probe. The vanA gene was also detected in the E. raffinosus isolate for which the Vm MIC was 16 micrograms/ml and the Tei MIC was 1 microgram/ml. The vanA gene was located on either a 34- or a 60-kb plasmid in all of the U.S. isolates examined. Pulsed-field gel electrophoresis demonstrated both intrahospital and interhospital diversity among Vmr enterococci in the United States and was more useful than plasmid analysis for epidemiologic studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Major trends in the microbial etiology of nosocomial infection
Schaberg, D. R., Culver, D. H., & Gaynes, R. P. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90346-y · Cited by 1,109
Emergence of Enterococcus as a Significant Pathogen
Moellering, R. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.6.1173 · Cited by 578
In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis
Sahm, D. F., Kissinger, J., Gilmore, M. S., Murray, P. R., Mulder, R., Solliday, J., & Clarke, B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1588 · Cited by 497
Murray, B. E., Singh, K. V., Heath, J. D., Sharma, B. R., & Weinstock, G. M. (1990) · Journal of Clinical Microbiology · doi:10.1128/jcm.28.9.2059-2063.1990 · Cited by 495
Livornese, L. L., Dias, S., Samel, C., Romanowski, B., Taylor, S., May, P., Pitsakis, P., Woods, G., Kaye, D., Levison, M. E., et al. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-2-112 · Cited by 481
Arthur, M., Molinas, C., & Courvalin, P. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.8.2582-2591.1992 · Cited by 338
New Mechanisms of Bacterial Resistance to Antimicrobial Agents
Epstein, F. H., Jacoby, G. A., & Archer, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102283240906 · Cited by 312
Transferable vancomycin and teicoplanin resistance in Enterococcus faecium
Leclercq, R., Derlot, E., Weber, M., Duval, J., & Courvalin, P. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.1.10 · Cited by 306
Restriction endonucleases for pulsed field mapping of bacterial genomes
McClelland, M., Jones, R., Patel, Y., & Nelson, M. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.15.5985 · Cited by 295
Cited by
Vancomycin-Resistant Enterococci
Cetinkaya, Y., Falk, P., & Mayhall, C. G. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.4.686 · Cited by 1,163
Infection with Vancomycin-Resistant Staphylococcus aureus Containing the vanA Resistance Gene
Chang, S., Sievert, D. M., Hageman, J. C., Boulton, M. L., Tenover, F. C., Downes, F. P., Shah, S., Rudrik, J. T., Pupp, G. R., Brown, W. J., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025025 · Cited by 1,095
Self-citationEmergence of Vancomycin Resistance in Staphylococcus aureus
Smith, T. L., Pearson, M. L., Wilcox, K. R., Cruz, C., Lancaster, M. V., Robinson-Dunn, B., Tenover, F. C., Zervos, M. J., Band, J. D., White, E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902183400701 · Cited by 1,088
Self-citationVancomycin-Resistant Enterococcal Infections
Murray, B. E. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421007 · Cited by 890
Genetic Analysis of a High-Level Vancomycin-Resistant Isolate of Staphylococcus aureus
Weigel, L. M., Clewell, D. B., Gill, S. R., Clark, N. C., McDougal, L. K., Flannagan, S. E., Kolonay, J. F., Shetty, J., Killgore, G. E., & Tenover, F. C. (2003) · Science · doi:10.1126/science.1090956 · Cited by 889
Self-citationMultiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the Future
Huycke, M. M., Sahm, D. F., & Gilmore, M. S. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0402.980211 · Cited by 718
McKinney, C. W., & Pruden, A. (2012) · Environmental Science & Technology · doi:10.1021/es303652q · Cited by 532
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525
Vancomycin-Resistant Staphylococcus aureus in the United States, 2002-2006
Sievert, D. M., Rudrik, J. T., Patel, J. B., McDonald, L. C., Wilkins, M. J., & Hageman, J. C. (2008) · Clinical Infectious Diseases · doi:10.1086/527392 · Cited by 483
Tenover, F. C., Lancaster, M. V., Hill, B. C., Steward, C. D., Stocker, S. A., Hancock, G. A., O’Hara, C. M., Clark, N. C., & Hiramatsu, K. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.4.1020-1027.1998 · Cited by 376
Self-citationVancomycin-Resistant Staphylococcus aureus Isolate from a Patient in Pennsylvania
Tenover, F. C., Weigel, L. M., Appelbaum, P. C., McDougal, L. K., Chaitram, J., McAllister, S., Clark, N., Killgore, G., O'Hara, C. M., Jevitt, L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.275-280.2004 · Cited by 370
Self-citationHanaki, H. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.2.199 · Cited by 366
Hegstad, K., Mikalsen, T., Coque, T. M., Werner, G., & Sundsfjord, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03226.x · Cited by 359
Tiwari, H. K., & Sen, M. R. (2006) · BMC Infectious Diseases · doi:10.1186/1471-2334-6-156 · Cited by 335
Kariyama, R., Mitsuhata, R., Chow, J. W., Clewell, D. B., & Kumon, H. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.8.3092-3095.2000 · Cited by 334
Montecalvo, M. A., Horowitz, H., Gedris, C., Carbonaro, C., Tenover, F. C., Issah, A., Cook, P., & Wormser, G. P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1363 · Cited by 318
Self-citationCore Genome Multilocus Sequence Typing Scheme for High-Resolution Typing of Enterococcus faecium
de Been, M., Pinholt, M., Top, J., Bletz, S., Mellmann, A., van Schaik, W., Brouwer, E., Rogers, M., Kraat, Y., Bonten, M., et al. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01946-15 · Cited by 314
Current perspectives on glycopeptide resistance
Woodford, N., Johnson, A. P., Morrison, D., & Speller, D. C. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.585 · Cited by 298
BACTERIAL URINARY TRACT INFECTIONS IN DIABETES
Patterson, J. E., & Andriole, V. T. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70383-4 · Cited by 294
Mannu, L., Paba, A., Daga, E., Comunian, R., Zanetti, S., Duprè, I., & Sechi, L. A. (2003) · International Journal of Food Microbiology · doi:10.1016/s0168-1605(03)00191-0 · Cited by 289
Diversity among Multidrug-Resistant Enterococci
Murray, B. E. (1998) · Emerging Infectious Diseases · doi:10.3201/eid0401.980106 · Cited by 285
Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States
Coque, T. M., Tomayko, J. F., Ricke, S. C., Okhyusen, P. C., & Murray, B. E. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.11.2605 · Cited by 279
Vancomycin‐Resistant Enterococci: Mechanisms and Clinical Observations
Gold, H. S. (2001) · Clinical Infectious Diseases · doi:10.1086/321815 · Cited by 258
Adhikari, A., Banerjee, P., Thornton, T., Jones, D. H., Adeoye, C., & Sherpa, S. (2023) · Microorganisms · doi:10.3390/microorganisms11061561 · Cited by 7
“The ARGs included β-lactams resistance genes (blatem−1 and blapse−1) [37], an aminoglycosides resistance gene (aac(3)-Iva) [37], a tetracycline resistance gene (tetA) [37], a trimethoprim resistance gene (dhfrI) [37], a sulfomamide resistance gene (sulI) [37], a chloramphenicol resistance gene (flo) [37], a phenicol r…”
BackgroundMethod
Metadata
- Authors
- Clark, N. C., Cooksey, R. C., Hill, B. C., Swenson, J. M., & Tenover, F. C.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1993-11
- Volume
- 37
- Issue
- 11
- Pages
- 2311-2317
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2117811009
- Cited by
- 395
- References
- 34
- FWCI
- 10.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.